Jenny, Laura A.
Liu, Pei-Kang
Kolesnikova, Masha
Duong, Jimmy
Kim, Angela H.
Levi, Sarah R.
Greenstein, Vivienne C.
Tsang, Stephen H.
Funding for this research was provided by:
National Institutes of Health (R01EY09076, 5P30CA013696, U01 EY030580, U54OD020351, R24EY028758, R24EY027285, 5P30EY019007, R01EY018213, R01EY024698, R01EY026682, R21AG050437)
Schneeweiss Stem Cell Fund, New York State (SDHDOH01-C32590GG-3450000)
Foundation Fighting Blindness New York Regional Research Center Grant (TA-NMT-0116-0692-COLU)
Nancy & Kobi Karp
Crowley Family Funds
The Rosenbaum Family Foundation
Alcon Research Institute
Gebroe Family Foundation
Research to Prevent Blindness (RPB) Physician-Scientist Award
Article History
Received: 1 February 2022
Accepted: 12 July 2022
First Online: 29 August 2022
Competing interests
: S.H. Tsang receives support from Abeona Therapeutics, Inc and Emendo. He is on the scientific advisory panel for Nanoscope Therapeutics and Medical Excellence Capital. He is also the founder of Rejuvitas.